Temporary authorisation for use of a non-approved medicine The Temporary [...]

Third-Party Logistics Third-Party Logistics (3PL) refers to outsourcing logistics to [...]

Early access authorisation for innovative medicines prior to reimbursement The [...]

Compassionate access to a drug without MA in exceptional cases [...]

General Agency for Health Products and Equipment (AP-HP) The General [...]

Definition French agency assessing, authorising and monitoring medicines and devicesThe [...]

Early access to certain drugs before final reimbursement decision Early [...]

Early Access pre-MA AP1 (Early Access pre-MA) is an authorisation [...]

Early Access post-MA AP2 (Early Access post-MA) enables patients to [...]

Added therapeutic benefit of a new treatment compared with standard [...]